Financials data is unavailable for this security.
Cash flow in NZDView more
In 2024, cash reserves at Rua Bioscience Ltd fell by 1.63m. However, Cash Flow from Investing totalled 2.21m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 3.74m for operations while cash used for financing totalled 94.78k.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0424 |
---|---|
Tangible book value per share | 0.0286 |
More ▼
Balance sheet in NZDView more
Current ratio | 3.22 |
---|---|
Quick ratio | 2.91 |
Total debt/total equity | 0.0218 |
---|---|
Total debt/total capital | 0.0214 |
More ▼